RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evoke Pharma Stock

Evoke Pharma Revenue 2024

Evoke Pharma Revenue

11.61 M USD

Ticker

EVOK

ISIN

US30049G1040

WKN

A1W6DP

In 2024, Evoke Pharma's sales reached 11.61 M USD, a 124.1% difference from the 5.18 M USD sales recorded in the previous year.

The Evoke Pharma Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e32.6715,24
2025e20.424,41
2024e11.6142,88
20235.1896,10
20222.5185,26
20211.6279,63
20200.02-300,00
2019--
2018--
2017--
2016--
2015--
2014--
2013--
2012--
2011--

Evoke Pharma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Evoke Pharma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Evoke Pharma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Evoke Pharma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Evoke Pharma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Evoke Pharma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Evoke Pharma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Evoke Pharma’s growth potential.

Evoke Pharma Revenue, EBIT and net profit per share

DateEvoke Pharma RevenueEvoke Pharma EBITEvoke Pharma Net Income
2026e32.67 M undefined11.56 M undefined1.38 M undefined
2025e20.4 M undefined1.55 M undefined178,704.01 undefined
2024e11.61 M undefined-4.3 M undefined-1.8 M undefined
20235.18 M undefined-7.43 M undefined-7.79 M undefined
20222.51 M undefined-7.79 M undefined-8.22 M undefined
20211.62 M undefined-8.15 M undefined-8.54 M undefined
202020,000 undefined-13.05 M undefined-13.15 M undefined
20190 undefined-7.15 M undefined-7.13 M undefined
20180 undefined-8.01 M undefined-7.57 M undefined
20170 undefined-11.23 M undefined-12.23 M undefined
20160 undefined-10.54 M undefined-10.75 M undefined
20150 undefined-11.82 M undefined-12.12 M undefined
20140 undefined-13.15 M undefined-13.25 M undefined
20130 undefined-2.6 M undefined-2.84 M undefined
20120 undefined-2 M undefined-2.02 M undefined
20110 undefined-2.41 M undefined-2.4 M undefined

Evoke Pharma stock margins

The Evoke Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Evoke Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Evoke Pharma.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Evoke Pharma's sales revenue. A higher gross margin percentage indicates that the Evoke Pharma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Evoke Pharma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Evoke Pharma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Evoke Pharma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Evoke Pharma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Evoke Pharma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Evoke Pharma Margin History

Evoke Pharma Gross marginEvoke Pharma Profit marginEvoke Pharma EBIT marginEvoke Pharma Profit margin
2026e96.1 %35.39 %4.24 %
2025e96.1 %7.6 %0.88 %
2024e96.1 %-37.06 %-15.52 %
202396.1 %-143.44 %-150.41 %
202285.26 %-310.36 %-327.49 %
202179.63 %-503.09 %-527.16 %
2020-300 %-65,250 %-65,750 %
201996.1 %0 %0 %
201896.1 %0 %0 %
201796.1 %0 %0 %
201696.1 %0 %0 %
201596.1 %0 %0 %
201496.1 %0 %0 %
201396.1 %0 %0 %
201296.1 %0 %0 %
201196.1 %0 %0 %

Evoke Pharma Aktienanalyse

What does Evoke Pharma do?

Evoke Pharma Inc. is a pharmaceutical company that was founded in 2007 and is based in San Diego, California. It focuses on developing innovative drugs for gastrointestinal disorders. Evoke Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Evoke Pharma's Sales Figures

The sales figures of Evoke Pharma originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Evoke Pharma’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Evoke Pharma's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Evoke Pharma’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Evoke Pharma stock

How much revenue did Evoke Pharma generate this year?

Evoke Pharma has achieved a revenue of 11.61 M USD this year.

How much was the turnover of the company Evoke Pharma compared to the previous year?

The revenue of Evoke Pharma has increased by 124.1% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Evoke Pharma?

The revenue of Evoke Pharma is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Evoke Pharma measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Evoke Pharma so important for investors?

The revenue of Evoke Pharma is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Evoke Pharma pay?

Over the past 12 months, Evoke Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evoke Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Evoke Pharma?

The current dividend yield of Evoke Pharma is .

When does Evoke Pharma pay dividends?

Evoke Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evoke Pharma?

Evoke Pharma paid dividends every year for the past 0 years.

What is the dividend of Evoke Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evoke Pharma located?

Evoke Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evoke Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evoke Pharma from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Evoke Pharma pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Evoke Pharma in the year 2023?

In the year 2023, Evoke Pharma distributed 0 USD as dividends.

In which currency does Evoke Pharma pay out the dividend?

The dividends of Evoke Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Evoke Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Evoke Pharma

Our stock analysis for Evoke Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evoke Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.